1. Auvert B, Taljaard D, Lagarde E, Sobngwi-Tambekou J, Sitta R, Puren A. Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 Trial. PLoS Med. 2005;2(2):1549–676.
2. Bailey RC, Moses S, Parker CB, Agot K, Maclean I, Krieger JN, et al. Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial. Lancet. 2007;369(9562):643–56. doi: 10.1016/S0140-6736(07)60312-2 17321310
3. Gray RH, Kigozi G, Serwadda D, Makumbi F, Watya S, Nalugoda F, et al. Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial. Lancet. 2007;369(9562):657–66. doi: 10.1016/S0140-6736(07)60313-4 17321311
4. WHO, UNAIDS. WHO/UNAIDS technical consultation on male circumcision and HIV prevention: research implications for policy and programming–conclusions and recommendations (6–8 March 2007). Montreux, Switzerland: World Health Organization and Joint United Nations Programme on HIV/AIDS, 2007.
5. WHO. Voluntary medical male circumcision for HIV prevention: Progress brief. Geneva, Switzerland: World Health Organization, 2018.
6. Patel EU, Kaufman MR, Dam KH, Van Lith LM, Hatzold K, Marcell AV, et al. Age differences in perceptions of and motivations for voluntary medical male circumcision among adolescents in South Africa, Tanzania, and Zimbabwe. Clin Infect Dis. 2018;66(Suppl 3):S173–S82. doi: 10.1093/cid/cix951 29617775
7. Kripke K, Njeuhmeli E, Samuelson J, Schnure M, Dalal S, Farley T, et al. Assessing progress, impact, and next steps in rolling out voluntary medical male circumcision for HIV prevention in 14 priority countries in Eastern and Southern Africa through 2014. PLoS One. 2016;11(7):e0158767. doi: 10.1371/journal.pone.0158767 27441648
8. Njeuhmeli E, Hatzold K, Gold E, Mahler H, Kripke K, Seifert-Ahanda K, et al. Lessons learned from scale-up of voluntary medical male circumcision focusing on adolescents: benefits, challenges, and potential opportunities for linkages with adolescent HIV, sexual, and reproductive health services. J Acquir Immune Defic Syndr. 2014;66(Suppl 2):S193–S9.
9. WHO, UNAIDS. Joint strategic action framework to accelerate the scale-up of voluntary medical male circumcision for HIV prevention in Eastern and Southern Africa, 2012–2016. Geneva, Switzerland: World Health Organization and Joint United Nations Programme on HIV/AIDS, 2011.
10. Toledo C, Davis SM, Thomas A, Kiggundu V, Cooney C, Watts DH. Making a pivot to maximize impact: age of clients at PEPFAR-supported voluntary medical male circumcision programs for HIV prevention, 2017. International AIDS Conference; Amsterdam, Netherlands: July 2018.
11. Kennedy CE, Yeh PT, Atkins K, Fonner VA, Sweat MD, O'Reilly K, et al. Economic incentives to increase uptake of voluntary medical male circumcision for HIV prevention: A systematic review and meta-analysis. PLoS One. [Manuscript under review].
12. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009;151(4):264–9. doi: 10.7326/0003-4819-151-4-200908180-00135 19622511
13. WHO. Models to inform fast tracking voluntary medical male circumcision in HIV combination prevention. Geneva, Switzerland: World Health Organization, 2017.
14. Awad SF, Sgaier SK, Ncube G, Xaba S, Mugurungi OM, Mhangara MM, et al. A Reevaluation of the voluntary medical male circumcision scale-up plan in Zimbabwe. PLoS One. 2015;10(11):e0140818. doi: 10.1371/journal.pone.0140818 26529596
15. Awad SF, Sgaier SK, Tambatamba BC, Mohamoud YA, Lau FK, Reed JB, et al. Investigating voluntary medical male circumcision program efficiency gains through subpopulation prioritization: insights from application to Zambia. PLoS One. 2015;10(12):e0145729. doi: 10.1371/journal.pone.0145729 26716442
16. Kripke K, Opuni M, Schnure M, Sgaier S, Castor D, Reed J, et al. Age Targeting of Voluntary Medical Male Circumcision Programs Using the Decision Makers’ Program Planning Toolkit (DMPPT) 2.0. PLoS One. 2016;11(7):e0156909. doi: 10.1371/journal.pone.0156909 27410966
17. O'Neill J, Tabish H, Welch V, Petticrew M, Pottie K, Clarke M, et al. Applying an equity lens to interventions: using PROGRESS ensures consideration of socially stratifying factors to illuminate inequities in health. J Clin Epidemiol. 2014;67(1):56–64. doi: 10.1016/j.jclinepi.2013.08.005 24189091
18. Carrasco MA, Grund JM, Davis SM, Ridzon R, Mattingly M, Wilkinson J, et al. Systematic review of the effect of economic compensation and incentives on uptake of voluntary medical male circumcision among men in sub-Saharan Africa. AIDS Care. 2018;30(9):1071–82. doi: 10.1080/09540121.2018.1453921 29566546
19. Higgins JPT, Green S. Chapter 8.5 The Cochrane Collaboration's tool for assessing risk of bias. In: Higgins JPT, Altman DG, Sterne JAC, on behalf of the Cochrane Statistical Methods Group and the Cochrane Bias Methods Group, editors. Cochrane Handbook for Systematic Reviews of Interventions, Version 5-1-0 [updated March 2011]. London, England: The Cochrane Collaboration; 2011.
20. Kennedy CE, Fonner VA, Armstrong KA, Denison JA, Yeh PT, O'Reilly KR, et al. The Evidence Project risk of bias tool: assessing study rigor for both randomized and non-randomized intervention studies. Syst Rev. 2019;8(1):3. doi: 10.1186/s13643-018-0925-0 30606262
21. WHO. WHO Handbook of Guideline Development. Geneva, Switzerland: World Health Organization; 2012.
22. Ashengo TA, Hatzold K, Mahler H, Rock A, Kanagat N, Magalona S, et al. Voluntary medical male circumcision (VMMC) in Tanzania and Zimbabwe: service delivery intensity and modality and their influence on the age of clients. PLoS One. 2014;9(5):e83642. doi: 10.1371/journal.pone.0083642 24801882
23. Barnabas RV, van Rooyen H, Tumwesigye E, Brantley J, Baeten JM, van Heerden A, et al. Uptake of antiretroviral therapy and male circumcision after community-based HIV testing and strategies for linkage to care versus standard clinic referral: a multisite, open-label, randomised controlled trial in South Africa and Uganda. Lancet HIV. 2016;3(5):e212–20. doi: 10.1016/S2352-3018(16)00020-5 27126488
24. Hellar AM, Boyee D, Mahler H, Plotkin M, Ng'wanakilala T, Curran K, et al. Mobile VMMC teams in Tanzania see older clients and have higher followup rates. Top Antivir Med. 2015;23(e-1):502.
25. Kaufman ZA, DeCelles J, Bhauti K, Hershow RB, Weiss HA, Chaibva C, et al. A sport-based intervention to increase uptake of voluntary medical male circumcision among adolescent male students: results From the MCUTS 2 cluster-randomized trial in Bulawayo, Zimbabwe. J Acquir Immune Defic Syndr. 2016;72(Suppl 4):S292–8.
26. Mahler H, Searle S, Plotkin M, Kulindwa Y, Greenberg S, Mlanga E, et al. Covering the last kilometer: using GIS to scale-up voluntary medical male circumcision services in Iringa and Njombe regions, Tanzania. Glob Health Sci Pract. 2015;3(3):503–15. doi: 10.9745/GHSP-D-15-00151 26374807
27. Miiro G, DeCelles J, Rutakumwa R, Nakiyingi-Miiro J, Muzira P, Ssembajjwe W, et al. Soccer-based promotion of voluntary medical male circumcision: A mixed-methods feasibility study with secondary students in Uganda. PLoS One. 2017;12(10):e0185929. doi: 10.1371/journal.pone.0185929 29016651
28. Montague C, Ngcobo N, Mahlase G, Frohlich J, Pillay C, Yende-Zuma N, et al. Implementation of adolescent-friendly voluntary medical male circumcision using a school based recruitment program in rural KwaZulu-Natal, South Africa. PLoS One. 2014;9(5):e96468. doi: 10.1371/journal.pone.0096468 24788339
29. Wambura M, Mahler H, Grund J, Larke N, Mshana G, Kuringe E, et al. Increasing voluntary medical male circumcision uptake among adult men in Tanzania. Aids. 2017;31(7):1025–34. doi: 10.1097/QAD.0000000000001440 28350578
30. Weiss SM, Zulu R, Jones DL, Redding CA, Cook R, Chitalu N. The Spear and Shield intervention to increase the availability and acceptability of voluntary medical male circumcision in Zambia: a cluster randomised controlled trial. Lancet HIV. 2015;2(5):e181–9. doi: 10.1016/S2352-3018(15)00042-9 26120594
31. DeCelles J, Hershow RB, Kaufman ZA, Gannett KR, Kombandeya T, Chaibva C, et al. Process evaluation of a sport-based voluntary medical male circumcision demand-creation intervention in Bulawayo, Zimbabwe. J Acquir Immune Defic Syndr. 2016;72(Suppl 4):S304–S8.
32. Katisi M, Daniel M. Safe male circumcision in Botswana: tension between traditional practices and biomedical marketing. Glob Public Health. 2015;10(5–6):739–56. doi: 10.1080/17441692.2015.1028424 25866013
33. Kilima SP, Shayo EH, Msovela J, Senkoro KP, Mayala BK, Mboera LEG, et al. The potential of involving traditional practitioners in the scaling up of male circumcision in the context of HIV prevention in Tanzania. Tanzania J Health Res. 2012;14(1):48–60.
34. Marshall E, Rain-Taljaard R, Tsepe M, Monkwe C, Taljaard D, Hlatswayo F, et al. Obtaining a male circumcision prevalence rate of 80% among adults in a short time: An observational prospective intervention study in the Orange Farm township of South Africa. Med. 2017;96(4):e5328.
35. Semo BW, Wirth KE, Ntsuape C, Barnhart S, Kleinman NJ, Ramabu N, et al. Modifying the health system to maximize voluntary medical male circumcision uptake: a qualitative study in Botswana. HIV AIDS (Auckl). 2018;10:1–8.
36. Alfonso YN, Bishai D, Nantongo A, Kakembo R, Kobusinge S, Kacker S, et al. Trends in the marginal cost of male circumcision in rural Rakai Uganda. J Acquir Immune Defic Syndr. 2016;73(5):564–71. doi: 10.1097/QAI.0000000000001144 27509246
37. Broughton EI, Karamagi E, Kigonya A, Lawino A, Marquez L, Lunsford SS, et al. The cost-effectiveness of three methods of disseminating information to improve medical male circumcision in Uganda. PLoS One. 2018;13(4):e0195691. doi: 10.1371/journal.pone.0195691 29672578
38. Galárraga O, Wamai RG, Sosa-Rubí SG, Mugo MG, Contreras-Loya D, Bautista-Arredondo S, et al. HIV prevention costs and their predictors: evidence from the ORPHEA Project in Kenya. Health Policy Plan. 2017;32(10):1407–16. doi: 10.1093/heapol/czx121 29029086
39. George G, Strauss M, Asfaw E. The cost of demand creation activities and voluntary medical male circumcision targeting school-going adolescents in KwaZulu-Natal, South Africa. PLoS One. 2017;12(6):e0179854. doi: 10.1371/journal.pone.0179854 28632768
40. Larson B, Tindikahwa A, Mwidu G, Kibuuka H, Magala F. How much does it cost to improve access to voluntary medical male circumcision among high-risk, low-income communities in Uganda? PLoS One. 2015;10(3):e0119484. doi: 10.1371/journal.pone.0119484 25774677
41. Marseille E, Kahn JG, Beatty S, Jared M, Perchal P. Adult male circumcision in Nyanza, Kenya at scale: the cost and efficiency of alternative service delivery modes. BMC Health Serv Res. 2014;14:31. doi: 10.1186/1472-6963-14-31 24450374
42. Soboil N, Cockburn J, Rech D, Taljaard D. A comparative analysis of two high-volume male medical circumcision (MMC) operational models with similar service delivery outcomes in different settings within Gauteng and KwaZulu-Natal provinces in South Africa: Urban Centre for HIV/AIDS Prevention Studies (CHAPS) versus rural-SACTWU Worker Health Program (SWHP). J Int AIDS Soc. 2012;15(S3):239.
43. Tchuenche M, Palmer E, Haté V, Thambinayagam A, Loykissoonlal D, Njeuhmeli E, et al. The cost of voluntary medical male circumcision in South Africa. PLoS One. 2016;11(10):e0160207. doi: 10.1371/journal.pone.0160207 27783612
44. Torres-Rueda S, Wambura M, Weiss HA, Plotkin M, Kripke K, Chilongani J, et al. Cost and cost-effectiveness of a demand creation intervention to increase uptake of voluntary medical male circumcision in Tanzania: spending more to spend less. J Acquir Immune Defic Syndr. 2018;78(3):291–9. doi: 10.1097/QAI.0000000000001682 29557854
45. Jennings L, Bertrand J, Rech D, Harvey SA, Hatzold K, Samkange CA, et al. Quality of voluntary medical male circumcision services during scale-up: a comparative process evaluation in Kenya, South Africa, Tanzania and Zimbabwe. PLoS One. 2014;9(5):e79524. doi: 10.1371/journal.pone.0079524 24801073
46. Curran K, Njeuhmeli E, Mirelman A, Dickson K, Adamu T, Cherutich P, et al. Voluntary medical male circumcision: strategies for meeting the human resource needs of scale-up in southern and eastern Africa. PLoS Med. 2011;8(11):e1001129. doi: 10.1371/journal.pmed.1001129 22140364
47. Herman-Roloff A, Llewellyn E, Obiero W, Agot K, Ndinya-Achola J, Muraguri N, et al. Implementing voluntary medical male circumcision for HIV prevention in Nyanza Province, Kenya: lessons learned during the first year. PLoS One. 2011;6(4):e18299. doi: 10.1371/journal.pone.0018299 21483697
48. Carrasco MA, Wilkinson J, Kasdan B, Fleming P. Systematic review of barriers and facilitators to voluntary medical male circumcision in priority countries and programmatic implications for service uptake. Glob Public Health. 2019;14(1):91–111. doi: 10.1080/17441692.2018.1465108 29695201
49. Price JE, Phiri L, Mulenga D, Hewett PC, Topp SM, Shiliya N, et al. Behavior change pathways to voluntary medical male circumcision: narrative interviews with circumcision clients in Zambia. PLoS One. 2014;9(11):e111602. doi: 10.1371/journal.pone.0111602 25375790
50. Plotkin M, Castor D, Mziray H, Küver J, Mpuya E, Luvanda PJ, et al. “Man, what took you so long?” Social and individual factors affecting adult attendance at voluntary medical male circumcision services in Tanzania. 2013;1(1):108–16.
51. Health Communication Capacity Collaborative (HC3). Technical considerations for demand generation for voluntary medical male circumcision in the context of the age pivot. Baltimore, Maryland: Johns Hopkins Center for Communication Programs (CCP), 2016.
52. Hatzold K, Mavhu W, Jasi P, Chatora K, Cowan FM, Taruberekera N, et al. Barriers and motivators to voluntary medical male circumcision uptake among different age groups of men in Zimbabwe: results from a mixed methods study. PLoS One. 2014;9(5):e85051. doi: 10.1371/journal.pone.0085051 24802746
53. Haacker M, Fraser-Hurt N, Gorgens M. Effectiveness of and financial returns to voluntary medical male circumcision for HIV prevention in South Africa: an incremental cost-effectiveness analysis. PLoS Med. 2016;13(5):e1002012. doi: 10.1371/journal.pmed.1002012 27138961
54. Shi C-F, Li M, Dushoff J. Evidence that promotion of male circumcision did not lead to sexual risk compensation in prioritized Sub-Saharan countries. PLoS One. 2017;12(4):e0175928. doi: 10.1371/journal.pone.0175928 28441458
55. Govender K, George G, Beckett S, Montague C, Frohlich J. Risk Compensation Following Medical Male Circumcision: Results from a 1-Year Prospective Cohort Study of Young School-Going Men in KwaZulu-Natal, South Africa. Int J Behav Med. 2018;25(1):123–30. doi: 10.1007/s12529-017-9673-0 28688094
56. Westercamp N, Agot K, Jaoko W, Bailey RC. Risk compensation following male circumcision: results from a two-year prospective cohort study of recently circumcised and uncircumcised men in Nyanza Province, Kenya. AIDS Behav. 2014;18(9):1764–75. doi: 10.1007/s10461-014-0846-4 25047688
57. Westercamp M, Jaoko W, Mehta S, Abuor P, Siambe P, Robert CB. Changes in male circumcision prevalence and risk compensation in the Kisumu, Kenya population 2008–2013. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. 2017;74(2):e30.
58. L’Engle K, Lanham M, Loolpapit M, Oguma I. Understanding partial protection and HIV risk and behavior following voluntary medical male circumcision rollout in Kenya. Health Educ Res. 2013;29(1):122–30. doi: 10.1093/her/cyt103 24293524
59. Mukudu H, Dietrich J, Otwombe K, Manentsa M, Hlongwane K, Haas-Kogan M, et al. Voluntary medical male circumcision (VMMC) for prevention of heterosexual transmission of HIV and risk compensation in adult males in Soweto: Findings from a programmatic setting. PLoS One. 2019;14(3):e0213571. doi: 10.1371/journal.pone.0213571 30845185
60. Ortblad KF, Harling G, Chimbindi N, Tanser F, Salomon JA, Bärnighausen T. Does incident circumcision lead to risk compensation? Evidence from a population cohort in KwaZulu-Natal, South Africa. JAIDS. 2019;80(3):269–75. doi: 10.1097/QAI.0000000000001912 30531298